Aster DM Quality Care Limited Stock Price Today (NSE: ASTERDM)

Aster DM Quality Care Limited

ASTERDMHospital
757.80+1.80 (+0.24%)
Market Closed

Fundamental Score

...

Aster DM Quality Care Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Aster DM Quality Care Limited share price today is 757.80, up +0.24% on NSE/BSE as of 1 September 2026. Aster DM Quality Care Limited (ASTERDM) is a Large-cap company in the Hospital sector with a market capitalisation of 71.92K (Cr). The 52-week high for ASTERDM share price is 891.30 and the 52-week low is 519.10. At a P/E ratio of 225.67x, ASTERDM is currently trading above its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 9.70% and a debt-to-equity ratio of 0.15.

Aster DM Quality Care Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
891.30
Low
757.80
Volume
7.3L
Change
+0.35%

Aster DM Quality Care Limited share price chart: 0.35% return over the past month. 52-week high ₹891.30, 52-week low ₹519.10.

Aster DM Quality Care Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
752.00767.00752.00765.2519.98L (Cr)
824.70828.80815.95818.006.06L (Cr)
824.25834.30819.25822.356.17L (Cr)
828.15834.75820.00824.303.27L (Cr)
854.95861.15822.50827.957.88L (Cr)
867.15883.20852.70854.9010.01L (Cr)
868.90891.30862.60867.1510.13L (Cr)
840.30875.35836.50869.7010.37L (Cr)
823.90874.00809.60844.4524.39L (Cr)
840.00856.75825.65842.1011.86L (Cr)

Aster DM Quality Care Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
825.05891.30752.00765.25-7.25%
786.95839.40767.75822.15+4.47%
724.50836.50711.30784.45+8.27%
701.05776.55701.05728.35+3.89%
677.03724.50652.00701.05+3.55%
618.20709.60603.80670.00+8.38%
556.55659.90519.10654.60+17.62%
615.00627.80531.25552.15-10.22%
672.90675.50587.70616.85-8.33%
679.00714.00647.50665.45-2.00%
626.00732.20621.30678.05+8.31%
598.40658.65594.50626.95+4.77%

AI Research Briefing

Powered by Gemini · 2026-04-08

Aster DM is a high-stakes consolidation bet; overpaying now for future synergies that may not arrive.

Research Confidence
6.0/10Moderate
WAR NARRATIVE TRADEConsolidation - 1M: -1.24%, 3M: 5.95%, 6M: 14.89%Expensive - P/E of 94.51x vs Industry P/E of 52.84x

WHAT'S HAPPENING NOW (last 2-4 weeks)

Aster DM Healthcare published a notice for a National Company Law Tribunal (NCLT) hearing regarding the Quality Care India Limited amalgamation scheme. The hearing is scheduled for May 22, 2026. Aster DM Healthcare also declared an interim dividend of for FY 2025-26, with April 3, 2026, as the record date.

CORE STORY (THE REAL GAME)

Aster DM is being priced as a consolidation play in the Indian healthcare space, specifically betting on the Quality Care India merger to unlock synergies and create a dominant player. The market is focused on the execution of this merger and subsequent expansion plans.

Why Now
  • Merger with Quality Care India Ltd progressing
  • Plans for significant bed expansion in India
  • Declaration of interim dividend
Potential Catalysts
  • Successful integration of Quality Care India
  • Announcement of new hospital projects or acquisitions
  • Strong quarterly earnings performance
Key Risks
  • High P/E ratio compared to industry peers
  • Significant pledged promoter shares
  • Dependence on merger synergies for valuation justification
Institutional Activity

FII decreased their holdings by 0.92%, while DII increased their holdings by 1.04%.

Macro Context

India's healthcare market is projected to reach $202.5 billion by 2030, providing a strong tailwind.

Cash Flow Quality

Yes - Free Cash Flow 5Y: ₹2417.08 Cr

3–6 Month Outlook

The next 3-6 months will be critical for Aster DM as it navigates the Quality Care India merger. Successful integration and realization of synergies are crucial for justifying the current valuation.

Primary Thesis Risk

Failure to realize merger synergies will lead to a significant valuation correction.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

9.70%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

11.35%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

25.11%

Average operating profit margin over 5 years

Dividend Yield

0.61%

Annual dividend as % of current share price

Aster DM Quality Care Limited Valuation Check

Poor

Price to Earnings (P/E)

225.67x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

48.79x

Average P/E of all peers in this sector

Market-cap Classification
Large-cap
Established & liquid; typically steadier returns.

Shareholding Pattern

Excellent

Promoter Holding

40.39%

% shares held by company founders/management

Good

FII Holding

17.18%

% shares held by foreign institutional investors

Excellent

DII Holding

27.57%

% held by domestic mutual funds, LIC, banks

Poor

Promoter Pledged %

40.66%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-81.22%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

21.60%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

-11.61%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

20.45%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

21.31%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.15x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

5.93x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

1.36K (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Aster DM Quality Care Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of ASTERDM across key market metrics for learning purposes.

Positive Indicators

9 factors identified

Strong Operating Margins (25.11%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Strong Revenue Growth (21.60%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Excellent EPS Growth (20.45% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (21.31% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.15)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (5.93x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Healthy Liquidity Position (Current Ratio: 1.99)

Observation: Strong short-term liquidity to meet obligations.

Analysis: Current ratio >1.5 indicates good working capital management.

Strong Cash Generation (₹1359.56 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Strong Institutional Confidence (FII+DII: 44.75%)

Observation: Significant professional investor participation.

Analysis: High institutional holding often signals thorough due diligence.

Risk Factors

6 factors identified

Below-Average Return on Equity (9.70%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Premium Valuation Risk (P/E: 225.67x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

High Price-to-Book Ratio (15.72x)

Observation: Trading at significant premium to book value.

Analysis: High P/B ratios may indicate overvaluation relative to asset base.

Profit Decline Concern (-81.22%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Limited Growth History (-11.61% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

High Share Pledging Risk (40.66%)

Observation: Significant promoter share pledging creates potential overhang.

Analysis: High pledging levels may create selling pressure during market downturns.

Aster DM Quality Care Limited vs Hospital Peers

Peer Comparison - Hospital

Compare Aster DM Quality Care Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
37.2/100
758
₹71917.90
225.7
Average
9.70%
Poor
11.35%
Average
0.2
Excellent
21.31%
Excellent
-11.61%
Poor
0.61%
62.1/100
8817
₹128448.55
61.5
Average
21.95%
Excellent
19.28%
Good
0.6
Good
66.81%
Excellent
19.03%
Excellent
0.22%
56.9/100
1014
₹107422.79
73.7
Average
14.33%
Average
13.43%
Average
0.3
Excellent
27.30%
Excellent
0.18%
56.8/100
917
₹73687.64
70.3
Average
11.08%
Average
12.83%
Average
0.3
Excellent
17.76%
Excellent
0.10%
68.3/100
1803
₹41592.95
51.0
Average
19.74%
Good
14.53%
Average
1.1
Average
25.05%
Excellent
0.22%
59.9/100
1443
₹35993.93
64.7
Average
15.15%
Good
16.85%
Good
0.3
Excellent
0.04%
13.9/100
806
₹33947.05
166.0
Average
11.01%
Average
9.35%
Poor
1.4
Average
3.71%
Average
24.04%
Excellent
0.00%
48.5/100
503
₹15618.15
105.3
Average
6.84%
Poor
10.16%
Average
0.1
Excellent
0.00%
65.5/100
1459
₹15270.28
53.5
Average
17.86%
Good
18.10%
Good
0.0
Excellent
0.23%
60/100
318
₹9829.95
52.3
Average
13.41%
Average
15.25%
Good
0.3
Excellent
0.07%
42.7/100
714
₹9663.25
424.2
Average
1.22%
Poor
7.43%
Poor
0.7
Good
20.22%
Excellent
0.00%

Aster DM Quality Care Limited PE Ratio History

Historical price-to-earnings ratio for ASTERDM — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 2025107.85₹616.855.7x
FY 20242.60₹513.95197.7x
FY 20238.53₹409.8048x
FY 202210.57₹231.1021.9x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Aster DM Quality Care Limited Dividend History

Annual cash dividends paid by ASTERDM — dividend yield 0.61%

Financial YearDividends Paid (₹ Cr)
FY 20256173.24 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Aster DM Quality Care Limited Quarterly Performance

Latest quarterly metrics for ASTERDM — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

21.60%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-81.22%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

-11.61%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

21.31%

Compounded annual net profit growth over 5 years

Aster DM Quality Care Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for ASTERDM — calculated from daily price history

52RSI 14
Neutral — RSI 52

Momentum is balanced — neither overbought nor oversold.

SMA 50
805
▼ Price below SMA 50 — Short-term bearish
SMA 200
694
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
658K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Aster DM Quality Care Limited Financial Statements

Annual income statement, balance sheet and cash flow for Aster DM Quality Care Limited (ASTERDM) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Aster DM Quality Care Limited

Loading latest quarterly results...

About ASTERDM (Aster DM Quality Care Limited)

Aster DM Healthcare Ltd is a prominent healthcare provider weaving a tapestry of comprehensive medical services within the vibrant Indian landscape. They stand as a multi-faceted e...ntity, extending care through a network of strategically located hospitals, conveniently accessible clinics, and fully integrated in-house pharmacies within those facilities. Their commitment to holistic well-being is evident in their diverse offerings, striving to cater to a wide spectrum of patient needs. Beyond direct patient care, they extend their expertise through consultancy services, sharing knowledge and best practices to elevate the broader healthcare ecosystem. Within the walls of Aster DM Healthcare's hospitals and clinics, a dedication to cutting-edge medical technology and patient-centric care is palpable. The organization aims to foster an environment of healing and trust, focusing on providing not just treatment, but also comfort and support. Through their in-house pharmacies, they ensure seamless access to essential medications, promoting adherence and contributing to better patient outcomes. This integrated approach, uniting various healthcare elements, allows for coordinated and efficient delivery of care. Beyond the core functions of hospitals, clinics, and pharmacies, Aster DM Healthcare further diversifies its reach into retail pharmacy and optical outlets. These extensions of the brand serve to bring healthcare accessibility closer to the community, catering to routine needs and promoting preventative care. Established in 1987 and rooted in Bengaluru, India, Aster DM Healthcare stands as a seasoned player in the Indian healthcare sector, continuously evolving to meet the dynamic needs of its growing patient base.

Company Details

Symbol:ASTERDM
Industry:Hospital
Sector:Hospital

Key Leadership

Dr. Mandayapurath Azad Moopen DTCD, M.D., MBBS
Founder, MD & Executive Chairman
Mr. Sunil Kumar M. R.
Chief Financial Officer
Mr. S. Ramesh Kumar
Group Chief Operating Officer

ASTERDM Share Price: Frequently Asked Questions

What is the current share price of Aster DM Quality Care Limited?

Aster DM Quality Care Limited (ASTERDM) trades at ₹757.80 on NSE and BSE. Market cap ₹71.92K (Cr). Educational data only.

What is the P/E ratio of Aster DM Quality Care Limited?

Aster DM Quality Care Limited has a P/E of 225.67x vs industry average 48.79x.

What is the Bull Run score for Aster DM Quality Care Limited?

Aster DM Quality Care Limited has a Bull Run score of 37.2/100 based on 25+ financial parameters.

Does Aster DM Quality Care Limited pay dividends?

Aster DM Quality Care Limited has a dividend yield of 0.61%. Past dividends don't guarantee future payments.

What is the ROE of Aster DM Quality Care Limited?

Aster DM Quality Care Limited has ROE of 9.70%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Aster DM Quality Care Limited?

Aster DM Quality Care Limited has debt-to-equity of 0.15.

Is Aster DM Quality Care Limited a good investment?

Bull Run gives Aster DM Quality Care Limited a score of 37.2/100. This is not investment advice — consult a SEBI-registered advisor.